Justyna Sosna
Kiel, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Pharmacological Inhibition of SLC33A1 Promotes Endoplasmic Reticulum Hyperoxidation and Induces Adaptive IRE1/XBP1s Signaling.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
An "epitomic" analysis of the specificity of conformation-dependent, anti-Aß amyloid monoclonal antibodies.
Journal: The Journal of biological chemistry
Published: August 04, 2020
Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
Journal: Journal of Alzheimer's disease : JAD
Published: November 28, 2019
Structure-based inhibitors of amyloid beta core suggest a common interface with tau.
Journal: eLife
Published: March 16, 2019
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
Journal: PloS one
Published: August 02, 2018
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Journal: Molecular neurodegeneration
Published: December 21, 2017
Underwater Leidenfrost nanochemistry for creation of size-tailored zinc peroxide cancer nanotherapeutics.
Journal: Nature communications
Published: August 02, 2016
Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells.
Journal: Oncotarget
Published: May 11, 2016
Cancer and necroptosis: friend or foe?
Journal: Cellular and molecular life sciences : CMLS
Published: March 14, 2016
Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.
Journal: Molecular and cellular biology
Published: October 15, 2015
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
Journal: Cardiovascular research
Published: July 17, 2015
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.
Journal: Cell communication and signaling : CCS
Published: November 18, 2014
Last Updated: 09/26/2026